Positive ID (PSID), a company that develops medical technologies for bio-threat detection, clinical diagnostics and diabetes management, has declared that its subsidiary, MicroFluidic Systems (MFSI), has both qualified and tendered a new government proposal, which would take the company’s entire pipeline of new government contracts to more than $37 million.
Most of the contracts that MFSI is planning to submit or has already submitted would be awarded in the year 2011. The latest proposal is for a cartridge based radiation dosimeter, which is built on the basis of MFSI’s Dragonfly technology.
MFSI was created in 2001 and specializes in producing automated instruments for a broad range of applications used to detect and process biological samples. So far, MFSI has been awarded more than $45 million in government contracts, most of which have come from the Department of Homeland Security and a few from the Department of Defense and the Health and Human Services.
The Microfluidics-based Bioagent Autonomous Networked Detector (M-Band) and the Dragonfly are the two major products of MFSI. The Dragonfly includes small microfluidic cartridges for detection and biological sample processing, and also clinical sample detection and processing of samples such as antibiotic-resistant bacteria, human papilloma virus, forensic applications, bio threat agents and environmental bacteria such as E.coli. The M-Band pathogen detection system is an ultra-sensitive bio aerosol monitor, which is completely autonomous and is capable of acting as an early warning system against biological attacks, while analyzing air samples non-stop for detecting bacteria, toxins and viruses and giving the results in just two hours.
According to Scott R Silverman, CEO and Chairman of PositiveID, MFSI”s pipeline and technologies are of high quality, which was the main reason for them to acquire MFSI. He further stated that their proven record of winning government contracts along with a wide range of commercial applications would prove to be beneficial for PositiveID both from a financial and an operational angle.